Species differences in the eeg response to epinephrine, 5-hydroxytryptamine and nicotine in brainstem transected animals,
dc.contributor.author | Knapp, Donald E. | en_US |
dc.contributor.author | Domino, Edward F. | en_US |
dc.date.accessioned | 2006-04-13T14:51:13Z | |
dc.date.available | 2006-04-13T14:51:13Z | |
dc.date.issued | 1963-06 | en_US |
dc.identifier.citation | Knapp, Donald E., Domino, Edward F. (1963/06)."Species differences in the eeg response to epinephrine, 5-hydroxytryptamine and nicotine in brainstem transected animals,." Neuropharmacology 2(1-2): 51-52. <http://hdl.handle.net/2027.42/32218> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T0C-474X42J-55/2/addd987e99aabb4245a8cea31ff5ff12 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/32218 | |
dc.description.abstract | Species differences have been observed in the EEG activation response to intravenous epinephrine, 5-hydroxytryptamine, and nicotine in rabbits, cats, dogs and monkeys. It was also found that a relatively high level of brainstem transection was required to induce a slow wave EEG pattern in the monkey. In midpontine** rabbits, cats and dogs and high pontine monkeys EEG activation was seen after 10-20 [mu]g/kg of nicotine. Similar doses of nicotine also produced EEG activation in prepontine S rabbits and cats but not in the prepontine dog. Also, whereas 4-8 [mu]g/kg of epinephrine and 30 [mu]g/kg 5-hydroxytryptamine produced EEG activation in the midpontine rabbit and cat, no such response was observed following the administration of these agents in the midpontine dog or high pontine monkey. | en_US |
dc.format.extent | 342305 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Species differences in the eeg response to epinephrine, 5-hydroxytryptamine and nicotine in brainstem transected animals, | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, The University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Pharmacology, The University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/32218/1/0000278.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0028-3908(63)90034-0 | en_US |
dc.identifier.source | Neuropharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.